Mobile Case Management for Heart Rehabilitation
(iCARE Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this research is to find out if doing cardiac rehab at home, or a mix of cardiac rehab at home and in the clinic, is as effective as coming in to the clinic for cardiac rehab.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Mobile Case Management for Heart Rehabilitation?
Research shows that home-based cardiac rehabilitation, which is part of the Mobile Case Management for Heart Rehabilitation, can improve access and participation, especially for older adults and those in rural areas. It emphasizes self-management, helping patients better understand and manage their heart conditions.12345
Is mobile case management for heart rehabilitation safe for humans?
How is the Mobile Case Management for Heart Rehabilitation treatment different from other treatments for heart rehabilitation?
Research Team
Thomas P Olson, Ph.D., M.S.
Principal Investigator
Mayo Clinic
Eligibility Criteria
This trial is for heart patients with conditions like a recent heart attack, angina, or those who've had certain heart surgeries. Participants need to have access to a smartphone or computer with internet and an email address. It's not for those using ventricular assist devices.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo cardiac rehabilitation through one of three arms: conventional center-based, center-based with mHealth, or home-based with mHealth, for approximately 3 months
Follow-up
Participants are monitored for safety and effectiveness after treatment, with additional follow-up at 12 months post cardiac rehab entry
Treatment Details
Interventions
- Center-Based Cardiac Rehab
- Home-Based Cardiac Rehab
- mHealth
Center-Based Cardiac Rehab is already approved in United States, European Union, Canada for the following indications:
- Myocardial Infarction
- Angina
- Heart Failure
- Revascularization
- Myocardial Infarction
- Angina
- Heart Failure
- Revascularization
- Myocardial Infarction
- Angina
- Heart Failure
- Revascularization
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator